The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
Liu
P
P
University of Toronto, Toronto, Ontario, Canada. peter.liu@utoronto.ca
Arnold
M
M
Belenkie
I
I
Howlett
J
J
Huckell
V
V
Ignazewski
A
A
LeBlanc
M H
MH
McKelvie
R
R
Niznick
J
J
Parker
J D
JD
Rao
V
V
Ross
H
H
Roy
D
D
Smith
S
S
Sussex
B
B
Teo
K
K
Tsuyuki
R
R
White
M
M
Beanlands
D
D
Bernstein
V
V
Davies
R
R
Issac
D
D
Johnstone
D
D
Lee
H
H
Moe
G
G
Newton
G
G
Pflugfelder
P
P
Roth
S
S
Rouleau
J
J
Yusuf
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000554:Ambulatory Care Facilities; D015906:Angioplasty, Balloon, Coronary; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000628:therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004347:Drug Interactions; D005081:Exercise Therapy / Q000379:methods; D015438:Health Behavior; D006266:Health Education / Q000379:methods; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D008943:Mitral Valve / Q000601:surgery; D009204:Myocardial Revascularization; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000628:therapy
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004071:Digitalis Glycosides; D000451:Mineralocorticoid Receptor Antagonists